Patent · US Expired

Agent for treating bradycardia and bradyarrhythmia

US4904673A · kind A · utility

2Cited by

2References

2Claims

0Family size

Assignee

Dr. Karl Thomae GmbH · DE

Inventors

Wolfgang Eberlein · Biberach, DE
Wolfhard Engel
Gerhard Mihm · Biberach, DE
Norbert Mayer · Gersthofen, DE
Adriaan De Jonge · Driebergen-Rijsenburg, NL

Key dates

Filing date	Jan 17, 1989
Grant date	Feb 27, 1990
Priority date	—
Expiry date	Jan 17, 2009

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

(.+-.)-1-[4-[Ethyl[2-(4-methoxyphenyl)-1-methylethyl]-amino]-1-oxobutyl]-N, N-dimethyl-4-piperidine carboxamide and (+)-1-[4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]-amino]-1-oxobutyl]N,N-d imethyl-4-piperidinecarboxamide, as well as the physiologically acceptable acid addition salts of these compounds are suitable for the treatment of bradycardia and bradyarrhythmia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.